Clinical Trials Browser

Terminated × INDUSTRY × Carcinoma, Small Cell × Clear all

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT03699956 2024-03-26

REPLATINUM

Phase 3 Terminated

18 enrolled

Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT02034123 2019-12-06

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

Phase 1 Terminated

29 enrolled 34 charts

Thoracic

Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT00537511 2019-11-19

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Phase 1/2 Terminated

22 enrolled 13 charts

Carcinoma, Small Cell

NCT00447421 2009-10-28

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Phase 1/2 Terminated

9 enrolled 6 charts

Thoracic

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Clinical Trials

Tamarack

REPLATINUM

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy